ArticleEuropean journal of medical research2025
Pan-cancer analysis identifies LMBR1L as a prognostic and immunological biomarker with validation in colorectal cancer.
Song Liang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.